- Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding https://www.nytimes.com/2022/11/29/health/lecanemab-alzheimers-drug.html 83 comments science
Linked pages
- How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved - The New York Times https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html 1 comment
- Lecanemab in Early Alzheimer’s Disease | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2212948 1 comment
- Alzheimer’s Drug Slows Cognitive Decline in Key Study - The New York Times https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html 0 comments
Related searches:
Search whole site: site:nytimes.com
Search title: Alzheimer’s Drug May Benefit Some Patients, New Data Shows - The New York Times
See how to search.